HK1168089A1 - Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same - Google Patents
Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the sameInfo
- Publication number
- HK1168089A1 HK1168089A1 HK12108646.7A HK12108646A HK1168089A1 HK 1168089 A1 HK1168089 A1 HK 1168089A1 HK 12108646 A HK12108646 A HK 12108646A HK 1168089 A1 HK1168089 A1 HK 1168089A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- group
- carboxylic acid
- pharmaceutical composition
- acid ester
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008121701 | 2008-05-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1168089A1 true HK1168089A1 (en) | 2012-12-21 |
Family
ID=41264679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12108646.7A HK1168089A1 (en) | 2008-05-07 | 2012-09-04 | Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
Country Status (10)
Country | Link |
---|---|
US (1) | US8367835B2 (fr) |
EP (2) | EP2484664B1 (fr) |
JP (1) | JP4746713B2 (fr) |
KR (1) | KR101409651B1 (fr) |
CN (1) | CN102089277B (fr) |
AU (1) | AU2009245121B2 (fr) |
CA (1) | CA2721815C (fr) |
ES (1) | ES2433008T3 (fr) |
HK (1) | HK1168089A1 (fr) |
WO (1) | WO2009136625A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120081119A (ko) * | 2009-09-04 | 2012-07-18 | 잘리커스 파마슈티컬즈 리미티드 | 통증 및 간질 치료를 위한 치환된 헤테로고리 유도체 |
JP2013028536A (ja) * | 2009-11-11 | 2013-02-07 | Dainippon Sumitomo Pharma Co Ltd | 環状アミン−1−カルボン酸エステル誘導体およびそれを含有する医薬組成物 |
ES2699806T3 (es) | 2012-04-18 | 2019-02-12 | SpecGx LLC | Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
ES2681952T3 (es) | 2013-03-15 | 2018-09-17 | SpecGx LLC | Forma farmacéutica sólida disuasoria del abuso de liberación inmediata con puntaje funcional |
PT3164117T (pt) | 2014-07-03 | 2023-12-12 | SpecGx LLC | Formulações de libertação imediata de dissuasão de abuso compreendendo polissacáridos não celulósicos |
EP3307725A1 (fr) * | 2015-06-11 | 2018-04-18 | Basilea Pharmaceutica International AG | Inhibiteurs de la pompe à efflux et utilisations thérapeutiques correspondantes |
EP3856160A4 (fr) | 2018-09-25 | 2022-07-06 | SpecGx LLC | Formes posologiques de capsules à libération immédiate anti-abus |
GB2584471A (en) * | 2019-06-05 | 2020-12-09 | James Frank Thomas Peter | Improvements in or relating to organic material |
EP4206184A1 (fr) | 2020-09-07 | 2023-07-05 | Sumitomo Pharma Co., Ltd. | Dérivé de phénol |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI239942B (en) | 2001-06-11 | 2005-09-21 | Dainippon Pharmaceutical Co | N-arylphenylacetamide derivative and pharmaceutical composition containing the same |
MY138086A (en) * | 2001-09-13 | 2009-04-30 | Smithkline Beecham Plc | Novel urea derivative as vanilloid receptor-1 antagonist |
MXPA05010444A (es) | 2003-04-03 | 2005-11-04 | Merck Patent Gmbh | Compuestos de carbonilo. |
GB0319150D0 (en) | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
WO2005040119A1 (fr) | 2003-10-01 | 2005-05-06 | Bayer Healthcare Ag | Tetrahydro-naphtalene et derives d'uree |
GB0325287D0 (en) | 2003-10-29 | 2003-12-03 | Merck Sharp & Dohme | Therapeutic agents |
JP4250582B2 (ja) * | 2004-09-30 | 2009-04-08 | 株式会社東芝 | 携帯端末 |
CA2601871A1 (fr) | 2005-03-19 | 2006-09-28 | Amorepacific Corporation | Nouveaux composes, isomere de ceux-ci, ou sels de ceux-ci acceptables sur le plan pharmaceutique utilises en tant qu'antagonistes de recepteur vanilloide; et compositions pharmaceutiques contenant ces composes |
CN101203483A (zh) | 2005-04-21 | 2008-06-18 | 大日本住友制药株式会社 | N-取代的苯乙酰胺衍生物和包含该衍生物的药物组合物 |
WO2007003962A2 (fr) | 2005-06-30 | 2007-01-11 | Prosidion Limited | Agonistes de gpcr |
US20080227823A1 (en) | 2007-03-12 | 2008-09-18 | Hassan Pajouhesh | Amide derivatives as calcium channel blockers |
-
2009
- 2009-05-07 EP EP12166546.7A patent/EP2484664B1/fr not_active Not-in-force
- 2009-05-07 KR KR1020107026843A patent/KR101409651B1/ko not_active IP Right Cessation
- 2009-05-07 WO PCT/JP2009/058644 patent/WO2009136625A1/fr active Application Filing
- 2009-05-07 CA CA2721815A patent/CA2721815C/fr not_active Expired - Fee Related
- 2009-05-07 US US12/991,224 patent/US8367835B2/en active Active
- 2009-05-07 CN CN200980126428.8A patent/CN102089277B/zh not_active Expired - Fee Related
- 2009-05-07 JP JP2010511078A patent/JP4746713B2/ja not_active Expired - Fee Related
- 2009-05-07 EP EP09742749A patent/EP2277861A4/fr not_active Withdrawn
- 2009-05-07 ES ES12166546T patent/ES2433008T3/es active Active
- 2009-05-07 AU AU2009245121A patent/AU2009245121B2/en not_active Ceased
-
2012
- 2012-09-04 HK HK12108646.7A patent/HK1168089A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2277861A1 (fr) | 2011-01-26 |
CN102089277A (zh) | 2011-06-08 |
KR20110010620A (ko) | 2011-02-01 |
JPWO2009136625A1 (ja) | 2011-09-08 |
EP2484664B1 (fr) | 2013-09-04 |
US8367835B2 (en) | 2013-02-05 |
EP2277861A4 (fr) | 2012-05-02 |
ES2433008T3 (es) | 2013-12-05 |
WO2009136625A1 (fr) | 2009-11-12 |
CA2721815C (fr) | 2014-06-10 |
KR101409651B1 (ko) | 2014-06-18 |
CN102089277B (zh) | 2014-02-12 |
JP4746713B2 (ja) | 2011-08-10 |
AU2009245121B2 (en) | 2013-08-01 |
AU2009245121A1 (en) | 2009-11-12 |
CA2721815A1 (fr) | 2009-11-12 |
US20120028937A1 (en) | 2012-02-02 |
EP2484664A1 (fr) | 2012-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1168089A1 (en) | Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same | |
WO2005105732A8 (fr) | Composes methylaryl- ou heteroarylamides substitues | |
EP3205642A3 (fr) | Dérivé d'amide, agent de lutte contre les nuisibles contenant le dérivé d'amide et procédé de lutte contre les organismes nuisibles | |
CA2565660A1 (fr) | Composes aryl- ou heteroarylamides ortho-substitues | |
ATE530066T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
WO2008108378A3 (fr) | Dérivé bicyclique d'oxomorpholine | |
MY168201A (en) | Agricultural And Horticultural Fungicidal Composition | |
MY177250A (en) | Novel nicotinamide derivative or salt thereof | |
WO2007087505A3 (fr) | Composés destinés au traitement des troubles du métabolisme | |
WO2005092895A3 (fr) | Composes acide propanoique beta piperidino methyle alpha aryle ou heteroaryle utilises comme antagonistes du recepteur orl1 | |
WO2008146871A1 (fr) | Nouveau dérivé de 1,2,3,4-tétrahydroquinoxaline qui a, comme substituant, un groupe phényle dans lequel est introduite une structure d'ester d'acide sulfonique ou une structure d'amide d'acide sulfonique et qui possède une activité de liaison aux récepteurs des glucocorticoïdes | |
WO2007137008A3 (fr) | Composés pour le traitement de troubles métaboliques | |
NO20054791L (no) | Forbindelser for behandling av stoffskiftesykdommer | |
NO20091858L (no) | Hydrobenzamid derivater som inhibitorer av HSP90 | |
MX2009008772A (es) | Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion. | |
EP2351764A8 (fr) | Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé | |
ATE526018T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
EP1634874A4 (fr) | Derive d'imidazolidine | |
ATE450496T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
ATE540675T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
BR112013015604A2 (pt) | novo derivado de isoquinolina substituído | |
EA201070603A1 (ru) | Лекарственное средство, активное в отношении невропатической боли | |
EP2604261A3 (fr) | Inhibiteur de production de SCCA-1 ayant un derive de carboxamide et/ou un sel de celui-ci en tant qu'ingredient actif | |
EP2511274A3 (fr) | Dérivé de polyamine | |
EA200900480A1 (ru) | Новые соединения индола, способ их получения и фармацевтические композиции, которые их содержат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190505 |